0001140361-11-027992.txt : 20110517
0001140361-11-027992.hdr.sgml : 20110517
20110516173741
ACCESSION NUMBER: 0001140361-11-027992
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110331
FILED AS OF DATE: 20110517
DATE AS OF CHANGE: 20110516
EFFECTIVENESS DATE: 20110517
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayer Capital Management, LP
CENTRAL INDEX KEY: 0001471149
IRS NUMBER: 262134101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1209
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-13640
FILM NUMBER: 11848989
BUSINESS ADDRESS:
STREET 1: 230 CALIFORNIA, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 4158744800
MAIL ADDRESS:
STREET 1: 230 CALIFORNIA, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
form13fhr.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: 3/31/2011
Check here if Amendment []; Amendment Number:
-------
This Amendment (Check only one.): [] is a restatement.
[] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Ayer Capital Management, LP
Address: 230 California Street, Suite 600
San Francisco, CA 94111
Form 13F File Number:
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Persons Signing this Report on Behalf of Reporting Manager:
Name: Tom Glaser
Title: CFO
Phone: 415-874-4800
Signature, Place, and Date of Signing:
/s/ Tom Glaser San Francisco, CA 5/16/2011
--------------------------------- --------------------------------- ----------
[Signature] [City, State] [Date]
Report Type (Check only one):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
List of Other Managers Reporting for this Manager:
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 2
Form 13F Information Table Entry Total: 31
Form 13F Information Table Value Total: $ 153,559
--------------
(In Thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
1 ACM Capital Partners, LLC
---- -------------------- ----------------------------------------------------
2 Jay Venkatesan
---- -------------------- ----------------------------------------------------
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
---------------------------- -------------- --------- -------- ------------------ ---------- -------- ---------------------
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
---------------------------- -------------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ----
AMARIN COM 023111906 5,385 736,100 CALL DEFINED 1,2 736,100 0 0
ARTHROCARE CORP COM 043136100 11,182 335,394 SH DEFINED 1,2 335,394 0 0
BIOSPECIFICS TECHNOLOGIES COM 090931106 5,513 216,207 SH DEFINED 1,2 216,207 0 0
CHELSEA THERAPEUTICS INTERNA COM 163428105 3,574 921,243 SH DEFINED 1,2 921,243 0 0
CELGENE CORP COM 151020104 12,294 213,537 SH DEFINED 1,2 213,537 0 0
CIGNA CORP COM 125509109 4,481 101,192 SH DEFINED 1,2 101,192 0 0
CORCEPT THERAPEUTICS INC COM 218352102 2,792 657,000 SH DEFINED 1,2 657,000 0 0
DENDREON CORP COM 24823Q107 6,334 169,217 SH DEFINED 1,2 169,217 0 0
ENDOCYTE INC COM 29269A102 6,547 764,000 SH DEFINED 1,2 764,000 0 0
EXPRESS SCRIPTS INC COM 302182100 3,583 64,422 SH DEFINED 1,2 64,422 0 0
HOSPIRA INC COM 441060100 5,796 105,000 SH DEFINED 1,2 105,000 0 0
IBIO INC COM 451033104 2,036 663,328 SH DEFINED 1,2 663,328 0 0
INTELLIPHARMACEUTICS INTERNA COM 458173101 1,866 620,000 SH DEFINED 1,2 620,000 0 0
INTERMUNE INC COM 45884X103 5,993 127,000 SH DEFINED 1,2 127,000 0 0
INTERMUNE INC COM 45884X903 18,876 400,000 CALL DEFINED 1,2 400,000 0 0
MCKESSON CORP COM 58155Q103 10,980 138,900 SH DEFINED 1,2 138,900 0 0
MEDCO HEALTH SOLUTIONS INC COM 58405U102 2,690 47,900 SH DEFINED 1,2 47,900 0 0
MITSUI SUGAR CO LTD ADR 606827202 4,073 971,000 SH DEFINED 1,2 971,000 0 0
NPS PHARMACEUTICALS INC COM 62936P103 1,919 200,312 SH DEFINED 1,2 200,312 0 0
NPS PHARMACEUTICALS INC COM 62936P903 4,790 500,000 CALL DEFINED 1,2 500,000 0 0
ONCOTHYREON INC COM 682324108 2,930 757,119 SH DEFINED 1,2 757,119 0 0
ARDEA BIOSCIENCES INC COM 03969P107 4,317 150,478 SH DEFINED 1,2 150,478 0 0
RAPTOR PHARMACEUTICAL CORP COM 75382F106 307 89,054 SH DEFINED 1,2 89,054 0 0
SHANGPHARMA CORP-ADR SPONSORED ADR 81943P104 3,875 319,977 SH DEFINED 1,2 319,977 0 0
THRESHOLD PHARMACEUTICALS COM NEW 885807206 2,567 1,666,666 SH DEFINED 1,2 1,666,666 0 0
TENGION INC COM 88034G109 721 353,360 SH DEFINED 1,2 353,360 0 0
UROPLASTY INC COM NEW 917277204 7,020 1,062,036 SH DEFINED 1,2 1,062,036 0 0
WELLPOINT INC COM 94973V107 6,370 91,276 SH DEFINED 1,2 91,276 0 0
WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 1,761 113,900 SH DEFINED 1,2 113,900 0 0
XENOPORT INC COM 98411C100 1,208 203,700 SH DEFINED 1,2 203,700 0 0
XENOPORT INC COM 98411C900 1,779 300,000 CALL DEFINED 1,2 300,000 0 0